Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 814.50% | -7.81% | -0.80% | 9.48% | -5.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 815.63% | -7.81% | -0.80% | 9.48% | -5.83% |
| Cost of Revenue | 124.85% | 294.97% | -1.66% | 23.42% | 19.77% |
| Gross Profit | 1,025.01% | -64.94% | -0.62% | 6.89% | -11.56% |
| SG&A Expenses | -32.29% | 8.96% | 5.96% | 23.23% | 26.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.28% | 102.96% | -0.47% | 10.77% | 10.12% |
| Operating Income | 208.08% | -150.61% | 0.33% | -11.25% | -14.68% |
| Income Before Tax | 182.32% | -126.63% | 3.72% | -9.68% | -13.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 182.32% | -126.63% | 3.72% | -9.68% | -13.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.55% | -57.96% | -12.57% | 12.50% | -7.04% |
| Net Income | 184.57% | -132.47% | 3.57% | -9.64% | -13.42% |
| EBIT | 208.08% | -150.61% | 0.33% | -11.25% | -14.68% |
| EBITDA | 219.16% | -159.99% | 0.43% | -11.54% | -15.92% |
| EPS Basic | 102.94% | 73.10% | 76.11% | -286.03% | -- |
| Normalized Basic EPS | 103.19% | 73.76% | 76.09% | -217.77% | -- |
| EPS Diluted | 102.94% | 73.10% | 76.11% | -286.03% | -- |
| Normalized Diluted EPS | 103.19% | 73.76% | 76.09% | -217.77% | -- |
| Average Basic Shares Outstanding | 2,781.56% | 770.11% | 303.74% | -71.60% | -- |
| Average Diluted Shares Outstanding | 2,781.56% | 770.11% | 303.74% | -71.60% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |